Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Inotiv, Inc.
  6. Summary
    NOTV   US45783Q1004

INOTIV, INC.

(NOTV)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
07/21/2021 07/22/2021 07/23/2021 07/26/2021 07/27/2021 Date
27.79(c) 29.04(c) 28.81(c) 29.38(c) 27.295 Last
55 033 57 721 58 145 45 939 51 476 Volume
-2.18% +4.50% -0.79% +1.98% -7.10% Change
More quotes
Estimated financial data (e) (USD)
Sales 2021 80,2 M - -
Net income 2021 -2,26 M - -
Net Debt 2021 - - -
P/E ratio 2021 -163x
Yield 2021 -
Sales 2022 126 M - -
Net income 2022 11,8 M - -
Net Debt 2022 - - -
P/E ratio 2022 39,7x
Yield 2022 -
Capitalization 465 M 465 M -
Capi. / Sales 2021 5,80x
Capi. / Sales 2022 3,69x
Nbr of Employees 409
Free-Float 62,3%
More Financials
Company
Inotiv, Inc, formerly Bioanalytical systems, Inc., is an international contract research company providing drug discovery and development services and analytical instruments. The Company focuses on providing drug developers with scientific research and analytical instrumentation. The Company operates in two segments: research services and research products. The research services segment provides research and... 
More about the company
All news about INOTIV, INC.
07/22INOTIV : to Report Third Quarter Fiscal 2021 Financial Results and Host Conferen..
AQ
07/21Certain Common Shares of Inotiv, Inc. are subject to a Lock-Up Agreement Endi..
CI
07/21Certain Options of Inotiv, Inc. are subject to a Lock-Up Agreement Ending on ..
CI
07/15SECTOR UPDATE : Health Care Stocks Lower Just Ahead of Closing Bell
MT
07/15SECTOR UPDATE : Health Care Stocks Lacking Much Traction
MT
07/15INOTIV : Buys Laboratories Assets in Tennessee for About $1.3 Million
MT
07/15INOTIV : Acquires Laboratory Instrumentation for Discovery and Development of No..
AQ
07/15Inotiv Acquires Laboratory Instrumentation for Discovery and Development of N..
CI
07/15Inotiv, Inc. acquired Physical assets of Novel Therapies for $1.3 million.
CI
07/12INOTIV : Buys MilliporeSigma's Genetic Toxicology Assets
MT
07/12INOTIV : Acquires Genetic Toxicology Assets from MilliporeSigma's BioReliance« p..
AQ
07/12Inotiv Appoints Gopala Krishna as Senior Vice President, Genetic Toxicology
CI
07/12Inotiv, Inc. acquired genetic toxicology assets from Sigma-Aldrich Corporatio..
CI
06/28Inotiv, Inc. Broadens Pathology Services to Include Medical Device Pathology ..
GL
06/28Inotiv, Inc. Broadens Pathology Services to Include Medical Device Pathology
CI
More news
News in other languages on INOTIV, INC.

- No features available -

More news
Analyst Recommendations on INOTIV, INC.
More recommendations
Chart INOTIV, INC.
Duration : Period :
Inotiv, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends INOTIV, INC.
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 1
Last Close Price 29,38 $
Average target price 36,00 $
Spread / Average Target 22,5%
EPS Revisions
Managers and Directors
Robert Leasure President, Chief Executive Officer & Director
Beth A. Taylor Chief Financial Officer, Secretary & VP-Finance
Gregory C. Davis Chairman
John Gregory Beattie Chief Operating Officer
Richard Allen Johnson Independent Director
Sector and Competitors
1st jan.Capi. (M$)
INOTIV, INC.0.00%465
MODERNA, INC.221.50%140 065
LONZA GROUP AG20.60%55 634
IQVIA HOLDINGS INC.38.02%47 396
CELLTRION, INC.-26.60%31 265
SEAGEN INC.-18.34%25 955